Vijiaratnam N, Girges C, Auld G, McComish R, et al. Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet 2025 Feb 4:S0140-6736(24)02808-3. doi: 10.1016/S0140-6736(24)02808.
PMID: 39919773